P
Park Dental Partners Inc
NASDAQ:PARK
Park Dental Partners Inc
NASDAQ:PARK
Price:
16.88
USD
-6.43%
Market Closed
Market Cap:
$69.1m
Relative Value
There is not enough data to reliably calculate the relative value of PARK.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
PARK
Relative Value
Base Case
Not Available
Multiples Across Competitors
PARK Competitors Multiples
Park Dental Partners Inc Competitors
Park Dental Partners Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
P
|
Park Dental Partners Inc
NASDAQ:PARK
|
76.7m USD | 0 | 0 | 0 | 0 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
96.8B USD | 0.2 | 54.7 | 14 | 14 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
67.3B EUR | 0.3 | 13.1 | 7.7 | 9.8 | |
| US |
|
Cigna Corp
NYSE:CI
|
70.4B USD | 0.3 | 11.8 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.5B EUR | 1.2 | 20.9 | 9.8 | 14.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 1.2 | 23.6 | 9.1 | 16.8 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22B USD | 2 | 22.3 | 12.3 | 16.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.7B USD | 1.6 | 24.7 | 12 | 17.3 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 0.6 | 11.4 | 5.4 | 10 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.2B USD | 11.4 | -26.8 | -28.9 | -26.2 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 0.8 | 13.8 | 7.3 | 9.8 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
